Monoclonal antibody is also a biological drug that can effectively resist BC, For example, trastuzumab and pertuzumab have been successfully used to treat patients with metastatic BC overexpressing HER2 by targeting Notch receptors (Shen and Reedijk, 2021). This evidence concerns the gene ERBB2 and breast cancer.